29J-33659-02063
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 857 / AZ
- Registered
- 2021-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Dose 1 — Pfizer-BioNTech
-
2021-02-06
Registered in v-safe
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-12
- 2021-02-19
-
2021-02-26
Dose 2 — Pfizer-BioNTech
- 2021-02-26
-
2021-02-27
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite, Pain, Skin sensitisation — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Skin sensitivity to touch and fabric. Light sensitivity. Loss of appetite. Body aches started the night of the second injection, subsided somewhat by evening of day after shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-28
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Myalgia, Oedema peripheral — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body achesFree text: Swelling and muscle aches were primarily around the armpit of the injected arm. Lymph nodes in armpot & neck on injection side seemed swolen.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Headache, Muscle or body achesAdult check-in
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Oedema peripheral — Feeling: Good · Site: Swelling · Muscle or body achesFree text: Most swelling/pain in armpit area of arm that received injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-03
- 2021-04-11
- 2021-05-28
- 2021-08-27
-
2022-02-27
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Decidual cast, Pre-existing disease, Uterine contractions abnormal, Uterine pain, Uterine spasm — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Extreme uterine cramping day after the booster. 2 days after booster I started to have contractions so painful I had to take a prescribed opiod. 3 days after booster I passed a decidual cast. Related to prior thick endo but unexpected and unusual.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-27
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-03-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Pfizer-BioNTech | |
| 2 | 2021-02-26 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Skin sensitivity to touch and fabric. Light sensitivity. Loss of appetite. Body aches started the night of the second injection, subsided somewhat by evening of day after shot.
Systemic reaction (other): Swelling and muscle aches were primarily around the armpit of the injected arm. Lymph nodes in armpot & neck on injection side seemed swolen.
Systemic reaction (other): Most swelling/pain in armpit area of arm that received injection
Release 11 — 12 months, dose 2
Symptoms: Extreme uterine cramping day after the booster. 2 days after booster I started to have contractions so painful I had to take a prescribed opiod. 3 days after booster I passed a decidual cast. Related to prior thick endo but unexpected and unusual.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Decidual cast | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Uterine contractions abnormal | · | · | ✓ |
| SD | Uterine pain | · | · | ✓ |
| SD | Uterine spasm | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Skin sensitisation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release